The research will be conducted at the PARCC Research Centre in Paris.
The PARCC (Paris Cardiovascular Research Center, UMR U970) successfully united a significant group of basic and clinical scientists who share a common vision and goals in cardiovascular research. PARCC research spans from fundamental molecular and cellular biology to integrated physiology, pathophysiology, biomarkers, genetics, and epidemiology. The overarching objective is to gain a deeper, more mechanistic understanding of pathological processes in vascular, cardiac, and kidney diseases, as well as the interplay between cardiology and oncology.
PARCC teams are also actively developing novel diagnostic and therapeutic strategies. Translational research is a core component of the PARCC’s mission, fostered through close collaboration with clinical laboratories and departments at the Hôpital Européen Georges Pompidou (HEGP).